4
Changes in Ownership
Merck & Co., Inc. Filed Acc 0001127602-22-025018
Executive Chair sold 470,000 shares at an average $98.66 ($46,372,118)
- Executive Chair acquired 470,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
FRAZIER KENNETH C · Executive Chair
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-11-03 | Exercise or conversion : show line 1 in the form | +235,000 | 935,653.06 | D | ||
| 2022-11-03 | Sale : show line 2 in the form | −214,617 | $98.68 | $21,178,084 | 721,036.06 | D |
| 2022-11-03 | Sale : show line 3 in the form | −20,383 | $99.09 | $2,019,804 | 700,653.06 | D |
| 2022-11-04 | Exercise or conversion : show line 4 in the form | +235,000 | 935,653.06 | D | ||
| 2022-11-04 | Sale : show line 5 in the form | −200,190 | $98.53 | $19,725,241 | 735,463.06 | D |
| 2022-11-04 | Sale : show line 6 in the form | −34,810 | $99.08 | $3,448,989 | 700,653.06 | D |
| Open-market sales · 470,000 sh · avg $98.66 · $46,372,118 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-11-03 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −235,000 | 470,769 | D |
| 2022-11-04 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −235,000 | 235,769 | D |
Loading xslF345X03/form4.xml…